Clinical Trial Update: Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations. [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant umbrella trial for patients with unresectable stage III non-small cell lung cancer and rare mutations is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lung Cancer Stage III, Mutation | Phase 2 | Status: RECRUITING